Aprogen Medicines Inc.
KSC: 007460.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Industrials
- Industry
- Industrial - Machinery
- CEO
- Ki-Cheol Lim
- Employees
- 245
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2005
- Market cap
- ₩95.3B
- Website
- https://www.aprogen-kic.com
Loading 007460…
Loading profile data…Frequently asked questions about 007460
What does Aprogen Medicines Inc. (007460.KS) do?
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it pro...
Where does 007460.KS trade?
Aprogen Medicines Inc. (007460.KS) trades on the Korea Exchange.
What sector is 007460.KS in?
Aprogen Medicines Inc. (007460.KS) operates in the Industrials sector, specifically in the Industrial - Machinery industry.
Who is the CEO of Aprogen Medicines Inc.?
Ki-Cheol Lim is the chief executive officer of Aprogen Medicines Inc. (007460.KS).
Where is Aprogen Medicines Inc. headquartered?
Aprogen Medicines Inc. is headquartered in South Korea.
Does 007460.KS pay a dividend?
Aprogen Medicines Inc. (007460.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 007460.KS go public?
Aprogen Medicines Inc. (007460.KS) completed its initial public offering in 2005.